Diabetic retinopathy is a leading cause of vision loss.
Recently co-authored this paper on a new potential therapeutic target…
Investigational Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema: An Expert Assessment
Recently co-authored this paper on a new potential therapeutic target…
Investigational Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema: An Expert Assessment